William E. Boden, MD, discusses his research in which he and his colleagues tried to replicate the results seen in the REDUCE-IT trial. His research was also presented at ACC.19 Scientific Session. More at: www.consultant360.com/cardiology.

In this podcast, Zubin Modi, MD, from the University of Michigan Medical School, discusses his research on the risk of CVD in young adults with end-stage renal disease. More at: www.consultant360.com/cardiology.

Deborah B. Horn, DO, MPH, from the University of Texas McGovern Medical School, talks about physical activity monitoring using fitness trackers, how to personalize each individual patient's activity plan, and the future of physical activity monitoring. More at: www.consultant360.com/cardiology.

In this podcast, Kevin Stewart and David Hill, MD, from the American Lung Association, discuss the ALA’s new State of the Air Report. Did your city pass or fail in air quality? What does that mean for your patients? Listen in to find out! More at: www.consultant360.com/pulmonology.

In part one of his series on stroke, Louis Caplan, MD, from Beth Israel Deaconess Medical Center talks about detecting penetrating artery disease, prevention of events, and the antiplatelet agents used to treat such events. More at: www.consultant360.com/neurology.

Mary A. O'Neal, MD, from Brigham and Women's Hospital, talks about hormones and migraine, the research gaps that need to be filled, and the lesson's we have learned about migraine so far. More at: www.consultant360.com/neurology.

In this podcast, Noam Alperin, PhD, from the University of Miami Miller School, talks about his research on the effect of sleep quality on cognitive function in elderly adults. More at: www.consultant360.com/neurology.

Hesham Abboud, MD, PhD, talks about his research on movement disorders in patients with multiple sclerosis, what the results mean for clinicians, and more. More at: www.consultant360.com/neurology.

Diane Lipscombe, PhD, and Christopher Moore, PhD, from Brown University, discuss their bioluminescence project, how it can affect neurological therapies in the future, and how you can be part of their ongoing research. More at: www.consultant360.com/neurology.

Diane Lipscombe, PhD, and Christopher Moore, PhD, from Brown University, discuss their bioluminescence project, how it can affect neurological therapies in the future, and how you can be part of their ongoing research. More at: www.consultant360.com/neurology.